Jack GreeneChief Technical and Manufacturing Officer at JucaBioSpeaker
Profile
Jack Greene is a dedicated professional with almost 30 years of industry experience focused on development of Drug Substances, Drug Products, and CMC Regulatory.
Jack leads the CMC function of JucaBio, a clinical-stage biotech. Prior to JucaBio, he served as Head of CMC at CinCor (acquired by AstraZeneca), Anagram Therapeutics, and held positions at Allena Pharmaceuticals, Alcresta Therapeutics, Alnara (acquired by Eli Lilly & Co), Altus Pharmaceuticals and Alkermes.
Jack is an Organic Chemist by training and lives in Boston with his family. In his spare time, he fixes broken things, cleans up messes, and combines these skills to restore vintage automobiles.
Agenda Sessions
CMC Regulatory Filings for NCE’s – How to Develop Module 3 for the FDA and the EU/UK without constraining Development Efforts
, 2:45pmView Session